D-Penicillamine treatment for chronic sensory ataxic neuropathy associated with Sjögren's syndrome

    loading  Checking for direct PDF access through Ovid

Abstract

Article abstract

Beneficial treatment has not been established for chronic sensory ataxic neuropathy associated with Sjögren's syndrome (CSAN-SS). We describe two patients with CSAN-SS who clinically improved in response to D-penicillamine treatment. Their neuropathic symptoms were lessened after D-penicillamine, and the results of electrophysiologic studies support the clinical improvement. D-Penicillamine can be considered a potentially beneficial agent in the treatment of CSAN-SS.

Related Topics

    loading  Loading Related Articles